心血管病一级预防病例发现策略的成本效果:一项建模研究
本研究基于英国初级保健数据库构建1万名30–74岁无心血管病或糖尿病成人的成本效果模型,比较机会性病例发现与按年龄或既往心血管风险估计优先排序的靶向策略。以每QALY价值2万英镑计,最优策略为按既往风险估计排序并邀请预测10年心血管风险≥12.76%的最高风险8%人群评估,较不开展病例发现更具效率。
要点
- 在健康成人中,按既往心血管风险估计靶向病例发现比全民病例发现更高效。
- 最优策略为邀请预测10年心血管风险≥12.76%的最高风险8%人群进行评估。
核心结论
- 在所有年龄范围内,使用既往心血管风险估计进行靶向病例发现比在健康成人中开展全民病例发现更高效。
研究设计与样本
- 成本效果建模研究,样本为从英国初级保健数据库The Health Improvement Network抽取的1万名30–74岁、无现存心血管病或糖尿病的个体。
- 采用离散事件模拟对邀请评估、评估心血管风险以及启动和坚持药物治疗的过程进行建模。
主要发现
- 最优策略为邀请<35%患者进行评估的概率为89.4%。
临床怎么用
- 在健康成人心血管病一级预防中,可优先按既往心血管风险估计排序并靶向邀请高风险人群评估,而非邀请全部成人。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Policies of active case finding for cardiovascular disease (CVD) prevention in healthy adults are common, but economic evaluation has not investigated targeting such strategies at those who are most likely to benefit. AIM: To assess the cost effectiveness of targeted case finding for CVD prevention. DESIGN AND SETTING: Cost-effectiveness modelling in an English primary care population. METHOD: A cohort of 10 000 individuals aged 30-74 years and without existing CVD or diabetes was sampled from The Health Improvement Network database, a large primary care database. A discrete-event simulation was used to model the process of inviting people for assessment, assessing cardiovascular risk, and initiation and persistence with drug treatment. Risk factors and drug cessation rates were obtained from primary care data. Published sources provided estimates of uptake of assessment, treatment initiation, and treatment effects. The researchers determined the lifetime costs and quality-adjusted life years (QALYs) with opportunistic case finding, and strategies prioritising and targeting patients by age or prior estimate of cardiovascular risk. This study reports on the optimum strategy if a QALY is valued at £20 000. RESULTS: Compared with no case finding, inviting all adults aged 30-74 years in a population of 10 000 yields 30.32 QALYs at a total cost of £705 732. The optimum strategy is to rank patients by prior risk estimate and invite 8% of those who are assessed as being at highest risk (those at ≥12.76% predicted 10-year CVD risk), yielding 17.53 QALYs at a cost of £162 280. There is an 89.4% probability that the optimum strategy is to invite <35% of patients for assessment. CONCLUSION: Across all age ranges, targeted case finding using a prior estimate of CVD risk is more efficient than universal case finding in healthy adults.
引用
- Crossan C, Lord J, Ryan R, et al. Cost effectiveness of case-finding strategies for primary prevention of cardiovascular disease: a modelling study. Br J Gen Pract. 2016. PMID: 27821671. doi:10.3399/bjgp16X687973
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。